Presenting details on initial response data from the ongoing VITALIZE DLBCL trial at the Immuno-Oncology 360°…
Año: 2023
Exelixis Announces Preliminary Fourth Quarter and Full Year 2022 Financial Results, Provides 2023 Financial Guidance, and Outlines Key Priorities and Milestones for 2023
– Cabozantinib franchise achieves approximately $1.4 billion in preliminary U.S. net product revenues for full year…
G20 was born out of an economic crisis, now has the opportunity to avoid a new crisis
The inclination for a country to turn inward in times of crisis is as old as…
QatarEnergy, Chevron Phillips Chemical to begin construction on integrated polymers complex in Ras Laffan Industrial City, Qatar
DOHA, Qatar–(BUSINESS WIRE)–QatarEnergy and Chevron Phillips Chemical Company LLC announced today they will proceed on construction…
NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2022
Generated Record Orders for Over 105 Spatial Biology Instruments in Q4, Representing 50% Growth Year-over-Year Q4…
Alipay+ promotes QR code connectivity, paving ways for a cash-free, mobile friendly travel experience in Chinese mainland for Asian consumers
– AlipayHK users are now able to pay for their metro rides in Shenzhen using their…
ForgeRock, Inc. (FORG) Shareholder Alert: Robbins LLP Informs Stockholders it is Investigating the Acquisition of ForgeRock, Inc. by Thoma Bravo
SAN DIEGO–(BUSINESS WIRE)–$FORG #FORG–Shareholder rights law firm Robbins LLP informs investors it is investigating the acquisition…
University of Phoenix College of Doctoral Studies Releases Whitepaper Examining Underrepresentation of African American Women in Corporate Senior Level Leadership
Authors Dr. Alfreda Goods, Dr. Adrian Allen and Dr. Lisa Langford explore how diversity, equity, and…
UEI Expands Its Wireless Connectivity Solutions With Enhanced Security, Sustainability, and Scalability
LAS VEGAS–(BUSINESS WIRE)–$UEIC #CE—Universal Electronics Inc. (UEI) (NASDAQ: UEIC), the global leader in wireless universal control…
Otsuka and Lundbeck Announce FDA Acceptance and Priority Review of sNDA for Brexpiprazole for the Treatment of Agitation Associated With Alzheimer’s Dementia
The supplemental new drug application (sNDA) for brexpiprazole in the treatment of agitation associated with Alzheimer’s…